Yizheng Wang

机构：Hebei Medical University, Fourth Hospital of Hebei Medical University, Huashan Hospital · ORCID：0000-0002-5301-7901

发表论文 26 篇 · 总被引 323 次 · h-index 9

代表论文

• miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1 (2016 · Oncotarget · 被引 95)
• Involvement of Receptor Tyrosine Kinase Tyro3 in Amyloidogenic APP Processing and β-Amyloid Deposition in Alzheimer's Disease Models (2012 · PLoS ONE · 被引 41)
• CAMK1D Inhibits Glioma Through the PI3K/AKT/mTOR Signaling Pathway (2022 · Frontiers in Oncology · 被引 24)
• Down‐Regulation of miR‐19a as a Biomarker for Early Detection of Silicosis (2016 · The Anatomical Record · 被引 19)
• Association of neural tube defects with gene polymorphisms in one-carbon metabolic pathway (2017 · Child s Nervous System · 被引 18)
• CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy (2023 · International Journal of Molecular Sciences · 被引 17)